BILLING NEWS

Polymerase Chain Reaction Testing amplified probe ñ CPB 650

Infectious agent quantification using nucleic acid (DNA or RNA) technique is conditionally eligible for specific diagnoses outlined in Clinical Policy Bulletin #0650 ñ Polymerase Chain Reaction Testing. All other indications are considered experimental and investigational.

SOURCE: Source
INDUSTRY NEWS TAGS: AETNA


SHARE THIS NEWS POST:

Billing News By TAG

Billing News By DATE